# A Study to Prove Non-inferior Immunogenicity of Grippol Quadrivalent Compared to Grippol Plus

> **NCT06385821** · PHASE3 · COMPLETED · sponsor: **NPO Petrovax** · enrollment: 824 (actual)

## Conditions studied

- Influenza
- Influenza A
- Influenza, Human
- Influenza Type B
- Flu
- Influenza A H3N2
- Influenza A H1N1
- Influenza Epidemic
- Flu, Human
- Acute Respiratory Infection
- Vaccine Reaction

## Interventions

- **BIOLOGICAL:** Grippol Quadrivalent
- **BIOLOGICAL:** Grippol Plus

## Key facts

- **NCT ID:** NCT06385821
- **Lead sponsor:** NPO Petrovax
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-09-21
- **Primary completion:** 2023-06-15
- **Final completion:** 2023-10-09
- **Target enrollment:** 824 (ACTUAL)
- **Last updated:** 2024-04-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06385821

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06385821, "A Study to Prove Non-inferior Immunogenicity of Grippol Quadrivalent Compared to Grippol Plus". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT06385821. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*